Optisk bildediagnostikk i gnagere
- Prosjektnummer
- 911202
- Ansvarlig person
- Bjørn Tore Gjertsen
- Institusjon
- Universitetet i Bergen
- Prosjektkategori
- Utstyr
- Helsekategori
- Blod og immunforsvar
- Forskningsaktivitet
In vitro crosstalk between fibroblasts and native human acute myelogenous leukemia (AML) blasts via local cytokine networks results in increased proliferation and decreased apoptosis of AML cells as well as increased levels of proangiogenic Interleukin 8.
Leuk Res 2005 Feb;29(2):185-96.
PMID: 15607368
CD34 expression in native human acute myelogenous leukemia blasts: differences in CD34 membrane molecule expression are associated with different gene expression profiles.
Cytometry B Clin Cytom 2005 Mar;64(1):18-27.
PMID: 15668952
Animal models of acute myelogenous leukaemia - development, application and future perspectives.
Leukemia 2005 May;19(5):687-706.
PMID: 15759039
Antiangiogenic therapy in acute myelogenous leukemia: targeting of vascular endothelial growth factor and interleukin 8 as possible antileukemic strategies.
Curr Cancer Drug Targets 2005 Jun;5(4):229-48.
PMID: 15975045
Proteomics in acute myelogenous leukaemia (AML): methodological strategies and identification of protein targets for novel antileukaemic therapy.
Curr Drug Targets 2005 Sep;6(6):631-46.
PMID: 16178797
CaM-kinaseII-dependent commitment to microcystin-induced apoptosis is coupled to cell budding, but not to shrinkage or chromatin hypercondensation.
Cell Death Differ 2006 Jul;13(7):1191-202. Epub 2005 nov 25
PMID: 16311514
Individualizing therapy in acute myeloid leukemia through modulation of signaling
Foredrag med webcasting, "Ung forsker pris" Onkologisk forum, Tromsø, 18. november 2005
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til Faglig rapportering, Helse Vest